Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Tecartus (brexucabtagene autoleucel) for the Treatment of Mantle Cell Lymphoma (MCL)
MCL is a rare type of Non-Hodgkin’s cancerous B-cell lymphoma. Credit: Kite, a Gilead Company.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Kognitic
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust,...
About
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust, insight-driven platform for life sciences, which accelerates our clients' drug development pipeline and investment decisions.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
Malvern Panalytical
Malvern Panalytical offers characterisation tools for molecular analysis and small...
About
Malvern Panalytical offers characterisation tools for molecular analysis and small drug discovery to help accelerate development for the pharmaceutical industry.
FollowMake an Enquiry